Deepening Radiotherapy Empowerment in Africa, Building Equal Anti-Cancer Defense | SHINVA Medical Shines at AFROG 2026
The 11th Annual AFROG (African Radiation Oncology Group) Conference, co-hosted with the Clinical Radiation Oncology Society of Kenya (CROSK), successfully concluded in Nairobi, Kenya, from July 16 to 18, 2026. As the most authoritative and influential summit in Africa’s radiation oncology sector, the conference focuses on strengthening multidisciplinary cancer diagnosis and treatment, as well as advancing equitable and high-quality cancer care across Africa. It gathers top oncologists, medical physicists, nursing specialists and healthcare policymakers nationwide, building a professional platform for academic exchanges, clinical practice sharing and industrial cooperation.
Africa is facing a severe cancer prevention and treatment challenge, with high incidences of breast, cervical, prostate and liver cancers. However, over 70% of African regions suffer from inadequate radiotherapy infrastructure, shortage of professional talents and incomplete quality control systems. European and American imported equipment is expensive with delayed after-sales support, failing to meet the clinical needs of grassroots African hospitals and restricting the development of local anti-cancer undertakings. Against this backdrop, AFROG 2026 serves as a key bridge for global medical enterprises to address local clinical pain points and boost regional medical capacity upgrading.
As the only Chinese silver-level sponsor for radiotherapy equipment at AFROG 2026, SHINVA Medical showcased a full portfolio of self-developed precision radiotherapy solutions at its featured booth, fully demonstrating the independent innovation strength and inclusive medical value of Chinese high-end radiotherapy equipment on Africa’s top academic stage.
During the conference, SHINVA Medical’s expert team delivered three keynote speeches tailored to grassroots clinical scenarios across Africa. The team highlighted the dual-photon linear accelerator specially adapted for African medium and small-sized hospitals and elaborated on low-cost VMAT technology. With outstanding advantages including simple daily operation, lower consumable costs and stronger local adaptability, SHINVA Medical’s solutions effectively broke the long-standing stereotype that high-end radiotherapy equipment can only be imported from Europe and the United States, winning wide recognition from African radiotherapy experts and practitioners.
SHINVA Medical’s booth remained highly popular throughout the three-day event, attracting radiotherapy specialists, oncology hospital investors and regional distributors from multiple East African countries. In-depth discussions covered equipment procurement, regional partnership and joint construction of clinical radiotherapy centers, securing preliminary cooperation intentions with several key hospitals in Kenya. In the highlight of the exhibition, Kenya’s Minister of Health and senior medical officials visited SHINVA Medical’s booth, inspecting the full range of radiotherapy equipment including medical accelerators and large-aperture simulation CT systems. Officials highly affirmed SHINVA Medical’s cost-effective, locally adaptable radiotherapy solutions and acknowledged its vital role in filling local radiotherapy infrastructure gaps and advancing standardized cancer care in Kenya.
Building on the academic achievements and customer resources gained from AFROG 2026, SHINVA Medical will further optimize its localized service system in Africa. The company will launch joint training programs for Chinese and African radiotherapy talents, invite African medical institutions to visit its domestic R&D and manufacturing bases, and establish a dedicated local after-sales and maintenance team in Kenya. These targeted measures will fundamentally solve local challenges including talent shortages, difficult equipment maintenance and high operational costs.
Moving forward, SHINVA Medical will continuously expand its presence in core African markets including Angola, Zambia, Mauritius and Nigeria, delivering stable, reliable and cost-effective Chinese radiotherapy systems to narrow the gap in regional cancer care resources. From complete operating room solutions in Algeria to advanced precision radiotherapy technologies debuted at Kenya’s top oncology conference, SHINVA Medical is steadily advancing its globalization strategy across Africa.
Sticking to independent technological innovation, SHINVA Medical will continue to promote global healthcare equity through academic communication, inclusive high-quality medical equipment and in-depth cross-border cooperation. Committed to building a more equal anti-cancer defense line, the brand will bring advanced Chinese radiotherapy technologies to more African regions and safeguard high-quality cancer treatment access for local patients.
